Cryptio — Automate digital asset accounting with audit-ready GAAP/IFRS reporting.

#48 Public Company 🇺🇸 United States

Apimeds Pharmaceuticals US, Inc.

BTC Holdings

₿1,000

BTC NAV: $82.3M

Holdings BTC vs USD value

₿1,000

$82.3M USD value · as of May 6, 2026

BTC Holdings (left)

USD Value (right)

Historical Holdings

XCE is a Bitcoin-focused public company planning to IPO with an executive recruitment operating business and a dedicated Bitcoin treasury strategy at its core.

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US (APUS) is a clinical-stage biotech company that bridges medical innovation with digital finance. Based in New Jersey, its primary focus is developing Apitox, a non-addictive bee venom-based treatment currently in FDA Phase III trials for knee osteoarthritis and multiple sclerosis pain.

Advanced metrics

Stacking Sats Framework IT delivers secure, scalable, and tailored technology solutions designed to help organizations seamlessly integrate Bitcoin treasury management and optimize digital asset operations across enterprise environments.

Holdings comparison

View all public companies →

#45 KULR Technology Group ₿1,021 #46 Nano Labs ₿1,000 #47 USBC, Inc. ₿1,000

#48 Apimeds Pharmaceuticals US, Inc. ₿1,000

#49 Ming Shing Group ₿833 #50 Fold Holdings Inc. ₿827 #51 Yueda Digital Holdings ₿819

Bitcoin Treasury Intelligence

Stay ahead of institutional Bitcoin accumulation.

Every week: new treasury entrants, mNAV movements, Digital Credit updates, and the data that matters to serious Bitcoin investors.

No spam. Unsubscribe anytime. Read by institutional analysts worldwide.